DUBLIN, March 24, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/fgnx4t/connected_drug) has announced the addition of the "Connected Drug Injection Devices" report to their offering.
Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Connected devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants.
What You Will Learn
- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
- What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
- What therapeutic areas are the current focus of connected devices?
- Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
- What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
- What does the current market for connected drug injection devices look like? What will it look like in 2020?
- What are the key market drivers for the growth of connected injection devices?
Who Should Read This Report
- Drug Developers - Device Suppliers - CMOs - Components/APIs - Testing/Validation - Clinical Trial Mgmt
- Pharma Managers - Biotech Managers - Drug Marketers - Industry Strategists - Financial Analysts - Management - Consultants
- Clinical Managers - Drug Distributors - Pharma Regulators - FDA Consultants - Managed Care Managers
Key Topics Covered:
1. Executive Summary
2. Connected Devices - The Opportunity
- Injectable Drug Development Trends
- The Rapid Rise of Prefilled Injection Devices
- Factors Driving Drug Self-Administration
- Therapeutic Demand Drivers
- The Impact of Developing Economies
3. Connectivity Technologies - Wireless Technologies - Bluetooth - Cellular - Near Field Communications - Wired Technologies
4. Connected Devices
5. Wearable Devices - Connected Autoinjectors - Non-drug Specific Connected Injectors - Self-powered Devices - Automated Connected Injectors - Vendor-specific Connectivity Platforms
6. Third Party Connectivity Devices
7. Near-term Markets for Connected Injection Devices - Anaphylaxis - Autoimmune Disease - Cardiovascular - Diabetes - Hormone Replacement
8. Market Factors
- Regulatory Requirements
- Data Security
- Patient Acceptance
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/fgnx4t/connected_drug
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-connected-drug-injection-devices-market-2016-2020---the-rapid-rise-of-prefilled-injection-devices-300241147.html
SOURCE Research and Markets